![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medical Care Technologies Inc (PK) | USOTC:MDCE | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0002 | -9.52% | 0.0019 | 0.0017 | 0.0021 | 0.0021 | 0.0015 | 0.002 | 5,319,499 | 21:02:25 |
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Title of securities to be registered
|
Amount to be registered
|
Proposed maximum of offering price per share
(1)
|
Proposed maximum aggregate
offering price
|
Amount of
registration fee
|
||||||||||||
Common stock, par value $0.001 per share
|
21,000,000
(2)
|
$
|
0.01
|
$
|
210,000.00
|
$
|
24.39
|
(1)
|
Pursuant to Rules 457(c) and 457(h)(1) of the Securities Act, the proposed maximum offering price per share is calculated upon the basis of the average of the high and low prices as reported on the Over the Counter Bulletin Board on May 26, 2011.
|
(2)
|
Represents shares of common stock issuable to consultants pursuant to consulting agreements with the Registrant.
|
(1)
|
Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2011, filed with the Commission on May 23, 2011;
|
(2)
|
Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Commission on April 1, 2011, as amended by amendment on Form 10-K/A filed with the Commission on June 1, 2011;
|
(3)
|
Current Reports on Form 8-K, filed with the Commission on February 16, 2011, March 24, 2011, April 22, 2011, May 6, 2011, and May 31, 2011, respectively;
|
(4) | Description of Common Stock in our Registration Statement on Form 8-A (file number 000-53665), filed pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with the Commission on May 7, 2009, including any amendments or reports filed for the purposes of updating such description. |
Incorporated by reference to
|
|||||
Exhibit
|
Document
|
Form
|
Filing Date
|
Exhibit Number
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
05/30/08
|
3.1
|
|
3.1(a) | Certificate of Amendment to Articles of Incorporation, effective September 17, 2010 | DEF 14C | 12/28/2010 | Apendix A | |
3.2
|
Bylaws.
|
S-1
|
05/30/08
|
3.2
|
|
4.1
|
Articles of Incorporation.
|
S-1
|
05/30/08
|
3.1
|
|
4.2
|
Specimen Stock Certificate.
|
S-1
|
05/30/08
|
4.1
|
|
5.1
|
Opinion of Eilenberg & Krause LLP*
|
||||
23.1
|
Consent of Eilenberg & Krause LLP (contained in Exhibit 5.1).
|
||||
23.2
|
Consent of Malone Bailey, LLP, independent registered public accounting firm.*
|
99.1
|
Management Services Agreement dated as of April 1, 2011 between Registrant and Low Sze Man.*
|
99.2
|
Administrative Services Agreement dated as of April 1, 2011 between Registrant and Liew Kit Ha.*
|
99.3
|
Management Advisory Services Agreement dated as of May 10, 2011 between Registrant and Yiu Chung Han.*
|
99.4
|
Consulting Services Agreement dated May 16, 2011 between Registrant and Nicola Suppa.*
|
*
|
Filed herewith.
|
1.
|
The undersigned Registrant hereby undertakes:
|
(a)
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
|
(b)
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof; and
|
(c)
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
2.
|
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
|
3.
|
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by a controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
|
MEDICAL CARE TECHNOLOGIES INC
.
|
||
By:
|
/s/Ning C. Wu
|
|
Name: Ning C. Wu
|
||
Title: Chief Executive Officer and Director (Principal Executive Officer)
|
||
By:
|
/s/ Hui Liu
|
|
Name: Hui Liu
|
||
Title: Treasurer and Director
(Principal Financial and Accounting Officer)
|
Signature
|
Title
|
Date
|
||
/s/ Ning C. Wu
|
Chief Executive Officer and Director
|
June 2, 2011
|
||
Ning C. Wu
|
(Principal Executive Officer)
|
|||
/s/
Hui Liu
|
Treasurer and Director
|
June 2, 2011
|
||
Hui Liu
|
(Principal Financial and Accounting Officer)
|
|||
/s/
Sean Lee Heung
|
Director
|
June 2, 2011
|
||
Sean Lee Heung
|
||||
/s/
Tang Ping
|
Director
|
June 2, 2011
|
||
Tang Ping
|
||||
/s/
Ping Hai Shen
|
Director
|
June 2, 2011
|
||
Ping Hai Shen
|
||||
5.1
|
Opinion of Eilenberg & Krause LLP*
|
||||
23.1
|
Consent of Eilenberg & Krause LLP (contained in Exhibit 5.1).
|
||||
23.2
|
Consent of Malone Bailey, LLP, independent registered public accounting firm.*
|
99.1
|
Management Services Agreement dated as of April 1, 2011 between Registrant and Low Sze Man.*
|
99.2
|
Administrative Services Agreement dated as of April 1, 2011 between Registrant and Liew Kit Ha.*
|
99.3
|
Management Advisory Services Agreement dated as of May 10, 2011 between Registrant and Yiu Chung Han.*
|
99.4
|
Consulting Services Agreement dated May 16, 2011 between Registrant and Nicola Suppa.*
|
*
|
Filed herewith.
|
1 Year Medical Care Technologies (PK) Chart |
1 Month Medical Care Technologies (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions